GSK competitorsClear all
GSK's top competitors include Merck, Johnson & Johnson, Roche, AstraZeneca, Takeda Pharmaceutical, Bayer and Eli Lilly.
| Save Comparison |  Merck Merck & Co (also known as Merck Sharp & Dohme) is a healthcare manufacturer and distributor of pharmaceuticals. |  Johnson & Johnson Johnson & Johnson is a global holding company that engages in the research and development, manufacture, and sale of a range of products in the healthcare field. |  Roche Roche (also known as F. Hoffmann-La Roch) is a biotech company operating through 2 segments: Pharmaceuticals and Diagnostics. |  AstraZeneca AstraZeneca is a global science-led biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines. |  Eli Lilly Eli Lilly and Company is a company that discovers, develops, manufactures, and markets pharmaceutical products. | |||
Founding Date | Founding Date 2000 | Founding Date 1891 | Founding Date 1886 | Founding Date 1896 | Founding Date 1999 | Founding Date 1781 | Founding Date 1863 | Founding Date 1876 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | ||||||||
Locations | Locations Brentford, GB HQ Boudouaou, DZ San Fernando, AR Abbotsford, AU Boronia, AU Wien, AT Minsk, BY see more | Locations New Brunswick, US HQ Buenos Aires, AR Chippendale, AU Wien, AT Minsk, BY Beerse, BE Brussel, BE see more | Locations Cambridge, GB HQ Alger, DZ Buenos Aires, AR Haedo, AR Macquarie Park, AU Macquarie Park, AU North Ryde, AU see more | Locations Tokyo, JP HQ The Rocks, AU Linz, AT Wien, AT Sint Jans Molenbeek, BE Santo Amaro, BR Toronto, CA see more | Locations Indianapolis, US HQ Melrose Park, AU Wien, AT Brussel, BE São Paulo, BR Toronto, CA Las Condes, CL see more | |||
Employees | Employees 99,4374% increase | Employees 74,0004% increase | Employees 134,5002% increase | Employees 101,4654% increase | Employees 76,1008% increase | Employees 47,4954% decrease | Employees 101,1683% decrease | Employees 35,0004% increase |
Valuation ($) | Valuation ($) 98.3 b | Valuation ($) 182.4 b | Valuation ($) 431.5 b | Valuation ($) N/A | Valuation ($) 154.6 b | Valuation ($) 53.8 b | Valuation ($) 52.8 b | Valuation ($) 218.9 b |
Twitter followers | Twitter followers 228.4 k | Twitter followers 212.7 k | Twitter followers 239.6 k | Twitter followers 235.1 k | Twitter followers 291.4 k | Twitter followers N/A | Twitter followers 180.1 k | Twitter followers 132 k |
Number of tweets (last 30 days) | Number of tweets (last 30 days) 78 | Number of tweets (last 30 days) 29 | Number of tweets (last 30 days) 121 | Number of tweets (last 30 days) 48 | Number of tweets (last 30 days) 53 | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 35 | Number of tweets (last 30 days) 29 |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) 11.6 | Average likes per tweet (last 30 days) 19.2 | Average likes per tweet (last 30 days) 3.2 | Average likes per tweet (last 30 days) 14.7 | Average likes per tweet (last 30 days) 35.9 | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 13.2 | Average likes per tweet (last 30 days) 5.6 |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) 91.03% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 26.45% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 88.68% | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 68.57% | Percentage of tweets with engagement (last 30 days) 55.17% |
Alexa Website Rank | Alexa Website Rank N/A | Alexa Website Rank 65117 | Alexa Website Rank 13415 | Alexa Website Rank 48352 | Alexa Website Rank 45419 | Alexa Website Rank 183252 | Alexa Website Rank 65651 | Alexa Website Rank 125956 |
Employee Rating | Employee Rating 3.9 | Employee Rating 4.2 | Employee Rating 4.2 | Employee Rating 4.3 | Employee Rating 4.2 | Employee Rating 3.9 | Employee Rating 4.4 | Employee Rating 4.1 |
Financial | ||||||||
Revenue (est.) | Revenue (est.) £33.8b (FY, 2019) | Revenue (est.) $48b (FY, 2020) | Revenue (est.) $82.1b (FY, 2019) | Revenue (est.) CHF63.8b (FY, 2019) | Revenue (est.) $24.4b (FY, 2019) | Revenue (est.) ¥3.3t (FY, 2020) | Revenue (est.) €43.5b (FY, 2019) | Revenue (est.) $24.5b (FY, 2020) |
Cost of goods | Cost of goods £11.9b (FY, 2019) | Cost of goods $15.5b (FY, 2020) | Cost of goods $27.6b (FY, 2019) | Cost of goods CHF18.4b (FY, 2019) | Cost of goods $4.9b (FY, 2019) | Cost of goods ¥1.1t (FY, 2020) | Cost of goods €17.5b (FY, 2019) | Cost of goods $5.5b (FY, 2020) |
Gross profit | Gross profit £21.9b (FY, 2019) | Gross profit $32.5b (FY, 2020) | Gross profit $54.5b (FY, 2019) | Gross profit CHF45.4b (FY, 2019) | Gross profit $19.5b (FY, 2019) | Gross profit ¥2.2t (FY, 2020) | Gross profit €26.1b (FY, 2019) | Gross profit $19.1b (FY, 2020) |
Net income | Net income £5.3b (FY, 2019) | Net income $7.1b (FY, 2020) | Net income $15.1b (FY, 2019) | Net income CHF14.1b (FY, 2019) | Net income $1.2b (FY, 2019) | Net income ¥44.3b (FY, 2020) | Net income €2.4b (FY, 2019) | Net income $6.2b (FY, 2020) |
Operating ⚠ | ||||||||
Countries | Countries N/A | Countries N/A | Countries 60 (FY, 2018) | Countries N/A | Countries 100 (FY, 2020) | Countries N/A | Countries 153 (FY, 2018) | Countries 120 (FY, 2019) |
Filed Trials Products (Oncology) | Filed Trials Products (Oncology) N/A | Filed Trials Products (Oncology) N/A | Filed Trials Products (Oncology) N/A | Filed Trials Products (Oncology) 3 (Dec, 2020) | Filed Trials Products (Oncology) N/A | Filed Trials Products (Oncology) 8 (Oct, 2020) | Filed Trials Products (Oncology) N/A | Filed Trials Products (Oncology) N/A |
Manufacturing Facilities | Manufacturing Facilities 87 (FY, 2016) | Manufacturing Facilities N/A | Manufacturing Facilities 97 (FY, 2019) | Manufacturing Facilities N/A | Manufacturing Facilities N/A | Manufacturing Facilities N/A | Manufacturing Facilities N/A | Manufacturing Facilities N/A |
Patients Included in Clinical Trials | Patients Included in Clinical Trials N/A | Patients Included in Clinical Trials N/A | Patients Included in Clinical Trials N/A | Patients Included in Clinical Trials 282.5 k (FY, 2019) | Patients Included in Clinical Trials 33 k (FY, 2017) | Patients Included in Clinical Trials N/A | Patients Included in Clinical Trials N/A | Patients Included in Clinical Trials N/A |
Phase I Trials Products | Phase I Trials Products 12 (FY, 2019) | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products 27 (FY, 2019) |
Phase I Trials Products (Oncology) | Phase I Trials Products (Oncology) N/A | Phase I Trials Products (Oncology) N/A | Phase I Trials Products (Oncology) N/A | Phase I Trials Products (Oncology) 43 (Dec, 2020) | Phase I Trials Products (Oncology) N/A | Phase I Trials Products (Oncology) 1 (Jul, 2019) | Phase I Trials Products (Oncology) N/A | Phase I Trials Products (Oncology) N/A |
Phase II Trials Products | Phase II Trials Products N/A | Phase II Trials Products 32 (Nov, 2020) | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products 12 (Jan, 2020) | Phase II Trials Products 9 (FY, 2019) |
Phase II Trials Products (Oncology) | Phase II Trials Products (Oncology) N/A | Phase II Trials Products (Oncology) N/A | Phase II Trials Products (Oncology) N/A | Phase II Trials Products (Oncology) 7 (Dec, 2020) | Phase II Trials Products (Oncology) N/A | Phase II Trials Products (Oncology) 8 (Oct, 2019) | Phase II Trials Products (Oncology) N/A | Phase II Trials Products (Oncology) N/A |
Phase III Trials Products | Phase III Trials Products 14 (FY, 2019) | Phase III Trials Products 25 (Nov, 2020) | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products 9 (Jan, 2020) | Phase III Trials Products 15 (FY, 2019) |
Phase III Trials Products (Neuroscience) | Phase III Trials Products (Neuroscience) N/A | Phase III Trials Products (Neuroscience) N/A | Phase III Trials Products (Neuroscience) N/A | Phase III Trials Products (Neuroscience) 2 (Dec, 2020) | Phase III Trials Products (Neuroscience) N/A | Phase III Trials Products (Neuroscience) 1 (Feb, 2020) | Phase III Trials Products (Neuroscience) N/A | Phase III Trials Products (Neuroscience) N/A |
Phase III Trials Products (Oncology) | Phase III Trials Products (Oncology) N/A | Phase III Trials Products (Oncology) N/A | Phase III Trials Products (Oncology) N/A | Phase III Trials Products (Oncology) 26 (Dec, 2020) | Phase III Trials Products (Oncology) N/A | Phase III Trials Products (Oncology) 5 (Oct, 2020) | Phase III Trials Products (Oncology) N/A | Phase III Trials Products (Oncology) N/A |
Projects in R&D Pipeline | Projects in R&D Pipeline N/A | Projects in R&D Pipeline 10 (May, 2018) | Projects in R&D Pipeline N/A | Projects in R&D Pipeline N/A | Projects in R&D Pipeline 171 (FY, 2020) | Projects in R&D Pipeline N/A | Projects in R&D Pipeline N/A | Projects in R&D Pipeline 66 (FY, 2016) |
Suppliers | Suppliers N/A | Suppliers N/A | Suppliers 3.5 k (Jun, 2018) | Suppliers N/A | Suppliers N/A | Suppliers N/A | Suppliers 86.4 k (FY, 2019) | Suppliers N/A |
Funding | ||||||||
Total funding raised | Total funding raised N/A | Total funding raised $ 5.6m | Total funding raised N/A | Total funding raised $ 2.8b | Total funding raised $ 1b | Total funding raised $ 57.8m | Total funding raised $ 3.5b | Total funding raised N/A |
For sources of this data, please see the company profile
View company profiles
Merck
HQ
Kenilworth, US
Employees
74,000↑ 4% increase
Merck & Co (also known as Merck Sharp & Dohme) is a healthcare manufacturer and distributor of pharmaceuticals.
View companyJohnson & Johnson
HQ
New Brunswick, US
Employees
134,500↑ 2% increase
Johnson & Johnson is a global holding company that engages in the research and development, manufacture, and sale of a range of products in the healthcare field.
View companyRoche
HQ
Basel, CH
Employees
101,465↑ 4% increase
Roche (also known as F. Hoffmann-La Roch) is a biotech company operating through 2 segments: Pharmaceuticals and Diagnostics.
View companyAstraZeneca
HQ
Cambridge, GB
Employees
76,100↑ 8% increase
AstraZeneca is a global science-led biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.
View company